...
首页> 外文期刊>Alimentary pharmacology & therapeutics. >Letter: Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis
【24h】

Letter: Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis

机译:信:他克莫司治疗类固醇难治性溃疡性结肠炎的近期疗效

获取原文
获取原文并翻译 | 示例

摘要

Sirs, We read the article by Schmidt et al. with great interest. They investigated the short-term efficacy of tacrolimus in 130 patients with steroid-refractory ulcerative colitis (UC). Median Lightiger score was 13 (range: 4-17) at baseline, and significantly decreased to 3 (range: 1-16) at week 4, and 3 (range: 0-14) at week 12. Clinical remission was achieved in 94 patients (72%) by week 12. On the other hand, 18 patients (14%) required colec-tomy. The authors also emphasized that concomitant thiopurine use was predictive of clinical remission and avoidance of surgery. These findings were very meaningful and showed the efficacy of tacrolimus therapy for severe UC in their real clinical experience.
机译:先生,我们阅读了Schmidt等人的文章。很有兴趣。他们研究了他克莫司对130例类固醇难治性溃疡性结肠炎(UC)患者的近期疗效。基线时Lightiger评分中位数为13(范围:4-17),第4周时显着降低至3(范围:1-16),而在第12周时显着降低为3(范围:0-14)。94例获得临床缓解到第12周时患者(72%)。另一方面,需要结肠切除术的患者18人(14%)。作者还强调,同时使用硫嘌呤可预测临床缓解和避免手术。这些发现非常有意义,并在他们的实际临床经验中显示了他克莫司治疗重度UC的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号